Jared Klingeisen is Vice President of Customer Success at Medable, serving in that role since the early days of the company in 2018...
With Informa Pharma Intelligence reporting that 76% of organizations have already decentralized some components of their trials, DCT is here to stay.
Today, organizations worldwide are revamping their research and development engines, adding decentralized capabilities to their traditional suite of services. As a pioneer in this space, Medable is best positioned to help empower this radical transformation to future-proof and enable next-generation clinical research at scale.
